These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1320651)

  • 1. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen.
    Takahashi M; Iketani T; Sasada K; Hara J; Kamiya H; Asano Y; Baba K; Shiraki K
    J Infect Dis; 1992 Aug; 166 Suppl 1():S58-62. PubMed ID: 1320651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction.
    Takahashi M; Kamiya H; Asano Y; Shiraki K; Baba K; Otsuka T; Hirota T; Yamanishi K
    Arch Virol Suppl; 2001; (17):161-72. PubMed ID: 11339545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
    Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
    Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response of elderly individuals to a live attenuated varicella vaccine.
    Levin MJ; Murray M; Rotbart HA; Zerbe GO; White CJ; Hayward AR
    J Infect Dis; 1992 Aug; 166(2):253-9. PubMed ID: 1321859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
    Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
    J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity to varicella-zoster virus.
    Arvin AM
    J Infect Dis; 1992 Aug; 166 Suppl 1():S35-41. PubMed ID: 1320649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibility of prevention of herpes zoster by use of varicella vaccine].
    Kawano S; Terada K; Yagi Y; Kataoka N
    Kansenshogaku Zasshi; 1998 Jul; 72(7):714-9. PubMed ID: 9745221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity.
    Watson B; Keller PM; Ellis RW; Starr SE
    J Infect Dis; 1990 Oct; 162(4):794-9. PubMed ID: 2169495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
    Nader S; Bergen R; Sharp M; Arvin AM
    J Infect Dis; 1995 Jan; 171(1):13-7. PubMed ID: 7798653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
    Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
    Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older.
    Levine MJ; Ellison MC; Zerbe GO; Barber D; Chan C; Stinson D; Jones M; Hayward AR
    Vaccine; 2000 Jun; 18(25):2915-20. PubMed ID: 10812235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
    Wittek AE; Arvin AM; Koropchak CM
    J Clin Microbiol; 1983 Nov; 18(5):1146-9. PubMed ID: 6315766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella vaccine: the American experience.
    Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
    J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.
    Hata A; Inoue F; Hamamoto Y; Yamasaki M; Fujikawa J; Kawahara H; Kawasaki Y; Honjo S; Koshiyama H; Moriishi E; Mori Y; Ohkubo T
    Diabet Med; 2016 Aug; 33(8):1094-101. PubMed ID: 26605507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.